Trial intelligence / Profile preview

MEOPA vs Placebo in Fiberoptic Bronchoscopy

NCT00392522Phase 3Unknown

Sponsor
Hospices Civils de Lyon
Start
Nov 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of nitrous oxide (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Efficacy in term of pain control Visual Analogic Scale. Status: unknown.

02

Drugs

nitrous oxide

Beyond the preview

Go deeper on NCT00392522.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00392522.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call